Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study

Background: Epilepsy is a common symptom of brain tumors and is often pharmacoresistent. Among new antiseizure medications (ASMs) Brivaracetam (BRV) has been approved as adjunctive treatment for focal seizures and it was tested in non-oncological patient populations. This is the first study that ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Maschio, Marta, Maialetti, Andrea, Mocellini, Cristina, Domina, Elisabetta, Pauletto, Giada, Costa, Cinzia, Mascia, Addolorata, Romoli, Michele, Giannarelli, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466736/
https://www.ncbi.nlm.nih.gov/pubmed/32973649
http://dx.doi.org/10.3389/fneur.2020.00813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466736/
https://www.ncbi.nlm.nih.gov/pubmed/32973649
http://dx.doi.org/10.3389/fneur.2020.00813

Ejemplares similares